SEARCH

SEARCH BY CITATION

References

  • Aronow HA, Feraru ER, Lipton RB. (1989) New-onset seizures in AIDS patients: etiology, prognosis, and treatment. Neurology 39(Suppl. 1):428.
  • Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC. (1994) Temporal trends in the incidence of HIV-1 related neurologic disease: multicenter AIDS cohort study. Neurology 44:18921900.
  • Barry M, Gibbons S, Back D, Mulcahy F. (1997) Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. Clin Pharmacokinet 32:194209.
  • Benedetti MS. (2000) Enzyme induction and inhibition by new antiepileptic drugs: a review of human trials. Fundam Clin Pharmacol 14:301319
  • Berbel-Garcia A, Latorre Ibarra A, Porta Etessam J, Martinez Salio A, Perez Martinez D, Siaz Diaz R, Toledo Heras M. (2000) Protease inhibitor–induced carbamazepine toxicity. Clin Neuropharmacol 23:216218.
  • Chadha DS, Handa A, Sharma SK, Varadarajulu P, Singh AP. (2000) Seizures in patients with HIV infection. J Assoc Physicians India 48:573576.
  • Cury RF, Wichert-Ana L, Sakamoto AC, Fernandes RM. (2004) Focal non-convulsive status epilepticus associated to PLEDs and intense focal hyperaemia in an AIDS patient. Seizure 13:358361.
  • Daikos GL, Cleary T, Rodriguez A, Fischl MA. (2003) Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis 7:394398.
  • Dal Pan GJ, McArthur JC, Harrison MJG. (1997) Neurological symptoms in HIV infection. In BergerJR, LevyRM (Eds) AIDS and nervous system. 2nd edition. Lippincott-Raven, Philadelphia , USA , pp. 141172.
  • Delanty N, Vaughan CJ, French JA. (1998) Medical causes of seizures. Lancet 352:383390.
  • Desai J. (2008) Perspectives on interactions between antiepileptic drugs and antimicrobial agents. Epilepsia 49 (Suppl. 6):4749.
  • Dore GJ, Law MG, Brew BJ. (1996) Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection. J Neuro AIDS 1:5969.
  • Enzensberger W, Fischer PA, Helm EB, Stille W. (1985) Value of EEG in AIDS. Lancet 1:10471048.
  • Garg RK. (1999) HIV medicine: HIV infection and seizures. Postgrad Med J 75:387390.
  • Holtzman DM, Kaku DA, So YT. (1989) New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 87:173177.
  • Hurwitz AA, Berman JW, Lyman WD. (1994) The role of blood- brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol 4:249256.
  • Kato Y, Fujii T, Mizoguchi N, Takata N, Ueda K, Feldman MD, Kayser SR. (2000) Potential interaction between ritonavir and carbamazepine. Pharmacotherapy 20:851854.
  • Kellinghaus C, Engbring C, Kovac S, Möddel G, Boesebeck F, Fischera M, Anneken K, Klönne K, Reichelt D, Evers S, Husstedt IW. (2008) Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure 17:2733.
  • Kuntz-Simon G, Orbert G. (1995) Sodium valproate, an anticonvulsant, stimulates human cytomegalovirus replication. J Gen Virol 76:151158.
  • Lauer MS, Rhoney DM. (1998) Tiagabine: a novel antiepileptic drug. Ann Pharmacother 32:11731180.
  • Lechner C, Auer D, Kumpfel T, Hesse J, Fuchs HH. (1998) Prolonged non-convulsive status epilepticus as an early clinical manifestation of epilepsy in connection with HIV infection—case report with EEG and MRI follow up. Fortschr Neurol Psychiatr 66:326330.
  • Lin RY, Smith JK. (1988) Hyper -IgE and human immunodeficiency virus infection. Ann Allergy 61:269272.
  • Lipton SA. (1994) AIDS-related dementia and calcium homeostasis. Ann NY Acad Sci 747:205224.
  • Lor E, Liu YQ. (1994) Neurological sequelae associated with foscarnet therapy. Ann Pharmacother 28:10351037.
  • Mazza DS, Grieco MH, Reddy MM, Meriney D. (1995) Serum IgE in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 74:411414.
  • McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S. (2001) Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. Am J Clin Nutr 74:679686.
  • Millogo A, Lankoande D, Yameogo I, Yaméogo AA, Sawadogo A, Sawadogo AB. (2004) New-onset seizures in patients with immunodeficiency virus infection in Bobo-Dioulasso Hospital. Bull Soc Pathol Exot 97:268270.
  • Modi G, Modi M, Martinus I, Saffer D. (2000) New-onset seizures associated with HIV infection. Neurology 55:15581561.
  • Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. (1996) Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol 196:496505.
  • Moulignier A, Mikol J, Pialoux G, Fenelon G, Gray F, Thiebaut JB. (1995) AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures. Am J Med 99:6468.
  • Navia B, Jordan B, Price R. (1986) The AIDS dementia complex: I clinical features. Ann Neurol 19:517524.
  • Ozkaya G, Kurne A, Unal S Oğuz KK, Karabudak R, Saygi S. (2006) Aphasic status epilepticus with periodic lateralized epileptiform discharges in a bilingual patient as a presenting sign of “AIDS-toxoplasmosis complex.” Epilepsy Behav 9:193196.
  • Pack AM, Morrell AJ. (2001) Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms, and therapeutic implications. CNS Drugs 15:633642.
  • Pascual-Sedano B, Iranzo A, Marti-Fabregas J, Domingo P, Escartin A, Fuuster M, Barrio JL, Sambeat MA. (1999) Prospective study of new-onset seizures in patients with HIV infection: etiologic and clinical aspects. Arch Neurol 56:609612.
  • Pesola GR, Westfal RE. (1998) New-onset generalized seizures with AIDS presenting at an emergency department. Acad Emerg Med 5:905911.
  • Provenzale JM, Jinkins JR. (1997) Brain and spine imaging findings in AIDS patients. Radiol Clin North Am 35:11271166.
  • Rachlis AR. (1998) Neurologic manifestations of HIV infection. Postgrad Med 103:111.
  • Report of the Quality Standards Subcommittee of the American Academy of Neurology. (1998) Evaluation and management of intracranial mass lesions in AIDS. Neurology 50:2126.
  • Romanelli F, Jennings HR, Nath A, Ryan M, Berger J. (2000) Therapeutic dilemma: the use of anticonvulsants in HIV positive individuals. Neurology 54:14041407.
  • Romanelli F, Ryan M. (2002) Seizures in HIV seropositive individuals: epidemiology and treatment. CNS drugs 16:9198.
  • Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, Desai A, Chandramuki A, Jayakumar PN, Shankar SK. (2000) Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989–96). Indian J Med Res 111:1423.
  • Satishchandra P, Mathew P, Gadre G, Nagarathna S, Chandramukhi A, Mahadevan A, Shankar SK. (2007) Cryptococcal meningitis: clinical, diagnostic and therapeutic overview. Neurol India 55:226232.
  • Shobha N, Satishchandra P, Mahadevan A, Desai A, Ravi V, Shankar SK. (2005) Clinical, radiological and pathological features of progressive multifocal leukoencephalopathy (PML) associated HIV clade C infection. (unpublished observations).
  • Shobha N, Satishchandra P, Desai A, Jayakumar PN, Ravi V, Shankar SK. (2006) Seizure as the initial manifestation of cerebral toxoplasmosis in HIV clade C infected patients. Presented at an International CME, at Chennai, India, February 10–12, 2006.
  • Sinha S, Satishchandra P. (2003) Nervous system involvement in asymptomatic HIV seropositive individuals—a cognitive and electrophysiological study. Neurol India 51:466469.
  • Sinha S, Satishchandra P, Nalini A, Ravi V, Subbakrishna DK, Jayakumar PN, Chandramuki A, Shankar SK. (2005) New-onset seizures among HIV infected drug naïve patients from south India. Neurology Asia 10:2933.
  • Solomon BA, Haut SR, Carr EM, Shlita AR. (1995) Neurotoxic reaction to lindane in an HIV seropositive patient. An old medication's new problem. J Fam Pract 40:291296.
  • Staal FT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D, Deresinski SC, Ross W. Sussman H, Raju PA. (1992) Intracellular glutathione levels in T-cell subsets decrease in HIV infected individuals. AIDS Res Hum Retroviruses 8:305311.
  • Tseng AL, Foisy M. (1999) Significant interactions with new antiretrovirals and psychotropic drugs. Ann Pharmacother 33:461473.
  • Udgirkar VS, Tullu MS, Bavdekar SB, Shaharao VB, Kamat JR, Hira PR. (2003) Neurological manifestations of HIV infection. Indian Pediatr 40:230234.
  • UNAIDS and WHO. Report on the global HIV/AIDS epidemic update, UNAIDS. UNAIDS/07.27E / JC1322E (English original, December 2007).
  • USPHS/IDSA. (1999) 1999 guidelines for the prevention and treatment of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 48:159.
  • Van Paesschen W, Bodian C, Maker H. (1995) Metabolic abnormalities and new-onset seizures in human immunodeficiency virus—seropositive patients. Epilepsia 36:146150.
  • Wong MC, Suite NDA, Labar DR. (1990) Seizures in human immunodeficiency virus infection. Arch Neurol 47:640642.
  • Zimmerman CL, Wen Y, Soria I, Pithavala YK. (1997) Evaluation of gastrointestinal absorption and metabolism. Drug Metab Rev 29:957975.